期刊文献+

GnRH-α长方案降调后LH水平对PCOS患者行IVF/ICSI结局的影响 被引量:5

Effect of LH level on the outcome of IVF/ICSI after GnRH-α long protocol pituitary down-regulation in PCOS patients
原文传递
导出
摘要 目的探讨控制性超促排卵(COH)过程中降调节后黄体生成素(LH)水平对多囊卵巢综合征(PCOS)患者体外授精/卵胞浆内单精子显微注射(IVF/ICSI)治疗结局的影响。方法回顾性分析首次接受IVF/ICSI治疗、黄体中期使用短效GnRH-α长方案垂体降调节的87例PCOS患者和同期因输卵管因素不孕接受短效GnRH-α长方案降调的277例患者,根据卵巢刺激启动日LH水平分为PCOS过度抑制组(A组,LH<1.2 U/L)与非过度抑制组(B组,LH≥1.2 U/L)、对照过度抑制组(C组,LH<1.2 U/L)与非过度抑制组(D组,LH≥1.2 U/L),分析4组患者在启动日不同血LH水平与控制性超促排卵特征及IVF临床结局的相关性。结果 A组与B组、C组与D组中垂体过度抑制者与非过度抑制者相比,垂体过度抑制者Gn用量、Gn刺激天数增加,获卵数、优质胚胎率低;A组胚胎种植率、临床妊娠率高于B组,但C组胚胎种植率、临床妊娠率低于D组(均P<0.05)。A组与C组、B组与D组中PCOS患者与对照组患者的比较中得出:PCOS患者虽然能够获取较多的卵母细胞,但受精率、胚胎种植率、临床妊娠率均无统计学差异(均P>0.05),而PCOS患者早期流产率和中度OHSS发生率显著高于对照组。结论虽然垂体非过度抑制的PCOS患者促排卵的卵巢反应性更高,但垂体过度抑制的PCOS患者有获得更佳IVF/ICSI结局的趋势。 Objective To explore the effect of luteinizing hormor,e (LH) level on tile outcome of in vitro fertilization (IVF) /intracy- toplasmic sperm injection (ICSI) 'after pituitary down-regulation during controlled ovulation hyperstimulation (COH) in patients with polycystic ovary syndrome (PCOS) . Methods A retrospective analysis was conducted in 87 patients with PCOS and 277 patients with tubal in- fertility undergoing IVF/ICS1 for the first time after pituitary down-regulati0n using short-term effect gonadotropin-releasing hormone-α (GnRH-α) long protocol, then the patients were divided into PCOS oversuppression group ( group A, LH〈1. 2 U/L) , PCOS non-oversuppression group (group B, LH ≥ 1.2 U/L), control oversuppression group (group C, LH〈1. 2 U/L) and control non-oversuppression group ( group D, LH ≥ 1.2 U/L) according to LH level on the starting day of ovarian stimulation. The correlations between serum LH levels on the starting day of ovarian stimulation, characteristics of COH, and the clinical outcome of IVF were analyzed in the four groups. Results Compared with group B and group D, the dose of gonadotropin (Gn) and the days of Gn stimulation increased in group A and group C, while the number of retrieved oocytes and the rate of high-quality embryos decreased ( P〈0. 05 ) . The rate of embryo implantation and clinical pregnancy rate in group A were statistically significantly higher than those in group B ( P〈0. 05 ) ; the rate of embryo implantation and clinical pregnancy rate in group C were statistically significantly lower than those in group D (P〈0. 05 ) . Compared with group C and group D, the patients in group A and group B had more oocytes, but there was no statistically significant difference in fertilization rate, embryo implantation rate, and clinical pregnancy rate (P〉0. 05 ) . However, the incidence rates of early ,abortion and moderate ovarian hyperstimulation syndrome (OHSS) in group A and group B were statistica
出处 《中国妇幼保健》 CAS 2017年第19期4764-4768,共5页 Maternal and Child Health Care of China
基金 山东省自然科学基金(ZR2012HL03) 山东省科技发展计划医药卫生项目(2011YD21014)
关键词 多囊卵巢综合征 体外受精-胚胎移植 黄体生成素 垂体抑制 长方案 Polycystic ovary syndrome In vitro fertilization-embryo transfer Luteinizing hormone Pituitary suppression Long protocol
  • 相关文献

参考文献4

二级参考文献44

  • 1Balasch J,Fabregues F.Is luteinizing hormone needed for optimal ovulation induction? Curr Opin Obstet Gynecol,2002,14:265-274. 被引量:1
  • 2Ruvolo G,Bosco L,Pane A,et al.Lower apoptosis rate in human cumulus cells after administration of recombinant luteinizing hormone to women undergoing ovarian stimulation for in vitro fertilization pro-cedures.Fertil Steril,2007,87:542-554. 被引量:1
  • 3Kolibianakis EM,Collins J,Tarlatzis B,et al.Are endogenous LH levels during ovarian stimulation for IVF using GnRH analogues associated with the probability of ongoing pregnancy? A systematic review.Hum Reprod Update,2006,12:3-12. 被引量:1
  • 4Balasch J,Fábregues F.LH in the follicular phase:neither too high nor too low.Reprod Biomed Online,2006,12:406-415. 被引量:1
  • 5Lisi F,Rinaldi L,Fishel S,et al.Use of recombinant LH in a group of unselected IVF patients.Reprod Biomed Online,2002,5:104-108. 被引量:1
  • 6Dumerin CI,Erb K,Fleming R,et al.Constituting The Luveris Pretreatment Group:Effects of recombinant LH treatment on folliculogenesis and responsiveness to FSH stimulation.Hum Reprod,2008,23:421-426. 被引量:1
  • 7Tarlatzis B,Towmergen E,Szamatowicz M,et al.The use of recombinant human LH (lutropin alfa) in the late stimulation phase of assisted reproduction cycles:a double-blind,randomized,prospective study.Hum Reprod,2006,21:90-94. 被引量:1
  • 8Recombinant human luteinizing hormone (LH) to support recombinant human follicle-stimulating hormone (FSH)-induced follicular development in LH-and FSH-deficient anovulatory women:a dose-fmding study.The European Recombinant Human LH Study Group.J Clin Endocrinol Metab,1998,83:1507-1514. 被引量:1
  • 9Westergaard LG,Laursen S,Andersen CY.Increased risk of early pregnancy loss by profound suppression of luteinizing hormone during ovarian stimulation in normogonadotropic women undergoing assisted reproduction.Hum Reprod,2000,5:1003-1008. 被引量:1
  • 10Humaidan P,Bungum L,Bungum M,et al.Ovarian response and pregnancy outcome releated to mid-follicular LH levels in women undergoing assisted reproduction with GnRH agonist downregulation and recombinant FSH stimulation.Hum Reprod,2002,17:2016-2021. 被引量:1

共引文献41

同被引文献62

引证文献5

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部